Authors: Hubeek, I Ramakers-van Woerden, NL Pieters, R Slater, R Beverloo, HB van Wering, ER Kamps, W Hahlen, K Veerman, AJP

Citation: I. Hubeek et al., TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia, BR J HAEM, 113(1), 2001, pp. 254-255

Authors: Ramakers-van Woerden, NL Pieters, R Slater, RM Loonen, AH Beverloo, HB van Drunen, E Heyman, M Moreno, TC Rots, MG van Wering, ER Kamps, WA Janka-Schaub, GE Veerman, AJP

Citation: Nl. Ramakers-van Woerden et al., In vitro drug resistance and prognostic impact of p16(INK4A)/p15(INK4B) deletions in childhood T-cell acute lymphoblastic leukaemia, BR J HAEM, 112(3), 2001, pp. 680-690

Authors: Ramakers-van Woerden, NL Pieters, R Loonen, AH Hubeek, I van Drunen, E Beverloo, HB Slater, RM Harbott, J Seyfarth, J van Wering, ER Hahlen, K Schmiegelow, K Janka-Schaub, GE Veerman, AJP

Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099